Our fear is that the savings will be on the back of poor people rather than highly profitable pharmaceutical companies and highly profitable abusive providers.

We're seeing how public programs are helping offset what is happening on the employer-based side.

It covers the kids, but it may leave the moms in the waiting room who care for the children without access to the doctor if she's sick.

We have a growing crisis. We aren't looking at solutions to the crisis. We're looking at cutting back the very program that has cushioned the impact.

It certainly raises a lot of serious questions, with a pharmaceutical company involved in financing the development of a Medicaid (reform plan).

Right now we have $10 billion in cuts on the table for the Medicare program in the U.S. Congress. So we're moving in the wrong direction.

These plans will save healthy people money but will be costly for people with more medical needs more.

There are serious moral and ethical questions that arise when a provider requires you to pay a fee that may not be affordable for everyone.